BSE Live
Jan 23, 16:01Prev. Close
68.50
Open Price
68.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:42Prev. Close
68.45
Open Price
68.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
66.40 (40)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 3.14 | 4.77 | 4.05 | 3.57 | 0.45 | |
| Diluted EPS (Rs.) | 3.11 | 4.60 | 4.05 | 3.57 | 0.45 | |
| Cash EPS (Rs.) | 8.57 | 8.83 | 8.60 | 7.46 | 3.72 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 43.19 | 45.04 | 42.20 | 37.88 | 34.82 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.19 | 45.04 | 42.20 | 37.88 | 34.82 | |
| Dividend / Share(Rs.) | 1.00 | 1.00 | 0.75 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 145.37 | 160.98 | 139.89 | 132.11 | 109.16 | |
| PBDIT/Share (Rs.) | 14.54 | 16.67 | 16.91 | 15.02 | 10.80 | |
| PBIT/Share (Rs.) | 9.10 | 12.40 | 12.36 | 11.12 | 7.53 | |
| PBT/Share (Rs.) | 4.04 | 5.96 | 4.81 | 4.21 | 1.05 | |
| Net Profit/Share (Rs.) | 3.13 | 4.56 | 4.05 | 3.55 | 0.45 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 10.00 | 10.35 | 12.08 | 11.37 | 9.88 | |
| PBIT Margin (%) | 6.26 | 7.70 | 8.83 | 8.41 | 6.89 | |
| PBT Margin (%) | 2.77 | 3.70 | 3.44 | 3.18 | 0.96 | |
| Net Profit Margin (%) | 2.14 | 2.83 | 2.89 | 2.68 | 0.41 | |
| Return on Networth / Equity (%) | 7.23 | 10.13 | 9.60 | 9.37 | 1.29 | |
| Return on Capital Employed (%) | 5.59 | 7.46 | 7.49 | 6.84 | 0.83 | |
| Return on Assets (%) | 2.45 | 3.27 | 2.85 | 2.66 | 0.34 | |
| Total Debt/Equity (X) | 0.84 | 1.01 | 1.03 | 1.26 | 1.45 | |
| Asset Turnover Ratio (%) | 114.00 | 115.59 | 98.71 | 98.95 | 84.50 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.13 | 1.10 | 1.01 | 0.98 | 1.01 | |
| Quick Ratio (X) | 0.75 | 0.73 | 0.64 | 0.59 | 0.60 | |
| Inventory Turnover Ratio (X) | 5.23 | 5.64 | 4.39 | 4.15 | 3.55 | |
| Dividend Payout Ratio (NP) (%) | 31.99 | 21.90 | 18.51 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 11.67 | 11.32 | 8.71 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 68.01 | 78.10 | 81.49 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 88.33 | 88.68 | 91.29 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 128.36 | 82.53 | 60.33 | 66.63 | 75.45 | |
| EV/Net Operating Revenue (X) | 0.69 | 0.46 | 0.41 | 0.48 | 0.66 | |
| EV/EBITDA (X) | 6.86 | 4.46 | 3.37 | 4.19 | 6.67 | |
| MarketCap/Net Operating Revenue (X) | 0.46 | 0.19 | 0.13 | 0.14 | 0.21 | |
| Retention Ratios (%) | 68.00 | 78.09 | 81.48 | 100.00 | 100.00 | |
| Price/BV (X) | 1.55 | 0.70 | 0.43 | 0.48 | 0.67 | |
| Price/Net Operating Revenue | 0.46 | 0.19 | 0.13 | 0.14 | 0.21 | |
| Earnings Yield | 0.05 | 0.15 | 0.23 | 0.20 | 0.02 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y